Interventional, Randomized, Double-Blind, Crossover, Placebo-Controlled, Multiple-Dose Lu AG06466 Phase IB Study in Patients With Fibromyalgia Using Neuroimaging to Investigate Its Pharmacodynamic Effects on Central Pain Processing and Neuroinflammation
Latest Information Update: 15 Feb 2022
At a glance
- Drugs Elcubragistat (Primary)
- Indications Fibromyalgia
- Focus Therapeutic Use
- Sponsors Lundbeck A/S
- 28 Jan 2022 Status changed from recruiting to discontinued.
- 27 Jul 2021 New trial record